☆ 4.7 Article

A single-cell landscape of pre- and post-menopausal high-grade serous ovarian cancer ascites

ISCIENCE (2023)

Related references

Note: Only part of the references are listed.

Article Oncology

Cancer statistics, 2023

Rebecca L. Siegel et al.

Summary: The American Cancer Society predicts that there will be 1,958,310 new cancer cases and 609,820 cancer deaths in the United States in 2023. While incidence trends for most cancers are favorable, prostate cancer saw a significant increase of 3% annually from 2014 to 2019. However, the overall cancer death rate continues to decline due to advances in treatment, with a 33% reduction since 1991.

CA-A CANCER JOURNAL FOR CLINICIANS (2023)

Add to Collection

Article Medicine, General & Internal

Cancer statistics in China and United States, 2022: profiles, trends, and determinants

Changfa Xia et al.

Summary: The study compared the latest cancer profiles, trends, and determinants between China and the USA in 2022. China has a higher incidence of lung cancer, while the USA has more cases of breast cancer. Recent years have seen a significant decrease in lung and colorectal cancer rates in the USA, while liver cancer rates have slightly increased. In China, rates for stomach, liver, and esophageal cancer have decreased gradually, but colorectal cancer rates have increased for the whole population.

CHINESE MEDICAL JOURNAL (2022)

Add to Collection

Review Oncology

Clinical relevance of tumour-associated macrophages

Mikael J. Pittet et al.

Summary: The interaction of tumour-associated macrophages (TAMs) with cancer and stromal cells in the tumour microenvironment enables and sustains most of the hallmarks of cancer. The authors of this Review examine the diversity of TAMs in various cancer indications, which is being revisited with the advent of single-cell technologies, and discuss the functional roles of different TAM states, the prognostic and predictive value of TAM-related signatures as well as approaches involving TAMs that are currently being or will soon be tested in clinical trials.

NATURE REVIEWS CLINICAL ONCOLOGY (2022)

Add to Collection

Article Oncology

Cancer treatment and survivorship statistics, 2022

Kimberly D. Miller et al.

Summary: The number of cancer survivors in the United States is increasing due to population growth, aging, and improved detection and treatment. The most prevalent cancers are prostate, skin melanoma, and colon and rectum for males, and breast, uterine corpus, and thyroid for females. Treatment disparities exist, with Black patients being less likely to be diagnosed with early-stage cancer and having lower surgical receipt rates.

CA-A CANCER JOURNAL FOR CLINICIANS (2022)

Add to Collection

Review Medicine, General & Internal

Lesions of the Ovary and Fallopian Tube

Dan L. Longo et al.

Summary: Lesions of the ovary and fallopian tube can be acute or chronic, and it is important to distinguish between benign and malignant causes. Referral to a gynecologic oncologist is often necessary for diagnostic assessment.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Add to Collection

Review Oncology

Current cancer burden in China: epidemiology, etiology, and prevention

Maomao Cao et al.

Summary: Cancer has become the leading cause of death in China, with significant changes in cancer epidemiology. Lung, colorectal, and gastric cancers are the most common types, while lung, liver, and stomach cancers are the deadliest. The 5-year survival rate for cancer has significantly improved in recent decades. Modifiable risk factors for cancer development include infectious agents, smoking, alcohol consumption, obesity, unhealthful dietary habits, and inadequate physical activity. The Chinese government has made efforts to reduce the cancer burden.

CANCER BIOLOGY & MEDICINE (2022)

Add to Collection

Article Biochemistry & Molecular Biology

A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells

Sijin Cheng et al.

Summary: This study conducted a pan-cancer analysis of single myeloid cells from 210 patients across 15 human cancer types, revealing distinct features of TIMs in different cancer types. For example, mast cells in nasopharyngeal cancer were associated with better prognosis, and pro-angiogenic TAMs showed diverse markers across different cancer types. The composition of TIMs appeared to be linked with certain features of somatic mutations and gene expressions.

CELL (2021)

Add to Collection

Article Biochemistry & Molecular Biology

A multi-omic single-cell landscape of human gynecologic malignancies

Matthew J. Regner et al.

Summary: Deciphering the regulatory mechanisms driving transcriptional programs in cancer cells is crucial for understanding tumor biology. The study utilized matched transcriptome and chromatin accessibility profiles at single-cell resolution to reveal complex cellular heterogeneity within ovarian and endometrial tumors. The findings demonstrate that malignant cells acquire novel regulatory elements to activate hallmark cancer pathways, and highlight the importance of intratumoral heterogeneity in cancer progression. Additionally, the study inferred the cell type-specific activity of transcription factors, indicating a reliance on oncogenic regulatory elements in cancer cells.

MOLECULAR CELL (2021)

Add to Collection

Article Oncology

Molecular characterization of high-grade serous ovarian cancers occurring in younger and older women

Olga T. Filippova et al.

Summary: Younger HGSOC patients more frequently carry pathogenic BRCA1 germline mutations and genomic features of HRD, while older patients preferentially display aging-related mutational signatures, fewer pathogenic BRCA1 germline mutations and genomic features of HRD.

GYNECOLOGIC ONCOLOGY (2021)

Add to Collection

Article Oncology

Single-cell dissection of cellular components and interactions shaping the tumor immune phenotypes in ovarian cancer

Milena Hornburg et al.

Summary: This study provides a detailed analysis of distinct T cell infiltration patterns in ovarian tumors, revealing the impact on responses to cancer immunotherapies and the underlying key determinants and biology of tumor immune phenotypes. The research highlights potential molecular mechanisms shaping these phenotypes and may inform therapeutic strategies for enhancing clinical benefit from cancer immunotherapies.

CANCER CELL (2021)

Add to Collection

Article Oncology

Assessing SPP1/Osteopontin (OPN) Splice Variants and Their Association to Nonmelanoma Skin Cancer by Absolute Quantification: Identification of OPN-5 Subvariants and Their Protein Coding Potential

Chu-Fang Chou et al.

Summary: The study evaluated the differential expression of SPP1/osteopontin (OPN) splice variants in nonmelanoma skin cancer compared to normal skin. Higher levels of certain splice variants were found in cutaneous squamous cell carcinomas (cSCCs) and basal cell carcinomas relative to normal skin.

CANCER INVESTIGATION (2021)

Add to Collection

Article Immunology

Chlamydia trachomatis, Pelvic Inflammatory Disease, and Epithelial Ovarian Cancer

Jorma Paavonen et al.

Summary: The link between Chlamydia trachomatis, pelvic inflammatory disease (PID), and epithelial ovarian cancer (EOC) may be relatively weak, but biologically plausible, requiring further investigation in future studies.

JOURNAL OF INFECTIOUS DISEASES (2021)

Add to Collection

Article Multidisciplinary Sciences

Evolution of core archetypal phenotypes in progressive high grade serous ovarian cancer

Aritro Nath et al.

Summary: The study reveals the core archetypes in progressive HGSOC and demonstrates consistent enrichment of subclones with the metabolism and proliferation archetype as resistance is acquired to multiple lines of therapy. The shifts in metabolism and proliferation are associated with treatment response and clonal heterogeneity in HGSOC.

NATURE COMMUNICATIONS (2021)

Add to Collection

Article Cell Biology

Characterizing the tumor microenvironment of metastatic ovarian cancer by single-cell transcriptomics

Susan Olalekan et al.

Summary: Understanding the cellular composition and interactions within the tumor microenvironment is crucial for successful cancer immunotherapies. By performing single-cell RNA sequencing of cells from six ovarian cancer patients, we identified nine major cell types and stratified immune cells into high T cell infiltration and low T cell infiltration groups. The study provides important insights into the immune response in ovarian tumors, highlighting potential anti-tumor responses in the high T cell infiltration group.

CELL REPORTS (2021)

Add to Collection

Article Oncology

The Repertoire of Serous Ovarian Cancer Non-genetic Heterogeneity Revealed by Single-Cell Sequencing of Normal Fallopian Tube Epithelial Cells

Zhiyuan Hu et al.

CANCER CELL (2020)

Add to Collection

Article Microbiology

Microbiota-Propelled T Helper 17 Cells in Inflammatory Diseases and Cancer

Matteo Bellone et al.

MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2020)

Add to Collection

Review Oncology

The untapped potential of ascites in ovarian cancer research and treatment

Caroline Elizabeth Ford et al.

BRITISH JOURNAL OF CANCER (2020)

Add to Collection

Article Oncology

Serologic markers of Chlamydia trachomatis and other sexually transmitted infections and subsequent ovarian cancer risk: Results from the EPIC cohort

Annika Idahl et al.

INTERNATIONAL JOURNAL OF CANCER (2020)

Add to Collection

Article Immunology

Single-cell transcriptome profiling reveals neutrophil heterogeneity in homeostasis and infection

Xuemei Xie et al.

NATURE IMMUNOLOGY (2020)

Add to Collection

Article Biochemistry & Molecular Biology

A single-cell landscape of high-grade serous ovarian cancer

Benjamin Izar et al.

NATURE MEDICINE (2020)

Add to Collection

Article Multidisciplinary Sciences

Th17-inducing autologous dendritic cell vaccination promotes antigen-specific cellular and humoral immunity in ovarian cancer patients

Matthew S. Block et al.

NATURE COMMUNICATIONS (2020)

Add to Collection

Review Oncology

Osteopontin: A Key Regulator of Tumor Progression and Immunomodulation

Hannah R. Moorman et al.

CANCERS (2020)

Add to Collection

Review Medicine, General & Internal

Treatment of epithelial ovarian cancer

Lindsay Kuroki et al.

BMJ-BRITISH MEDICAL JOURNAL (2020)

Add to Collection

Review Oncology

Epithelial ovarian cancer: Evolution of management in the era of precision medicine

Stephanie Lheureux et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2019)

Add to Collection

Article Biochemistry & Molecular Biology

Comprehensive Integration of Single-Cell Data

Tim Stuart et al.

CELL (2019)

Add to Collection

Review Pharmacology & Pharmacy

Osteopontin as a multifaceted driver of bone metastasis and drug resistance

Xiaocong Pang et al.

PHARMACOLOGICAL RESEARCH (2019)

Add to Collection

Article Oncology

Ovarian cancer stem cells and macrophages reciprocally interact through the WNT pathway to promote pro-tumoral and malignant phenotypes in 3D engineered microenvironments

Shreya Raghavan et al.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)

Add to Collection

Article Oncology

Interleukin-17 is associated with expression of programmed cell death 1 ligand 1 in ovarian carcinoma

Aeri Aotsuka et al.

CANCER SCIENCE (2019)

Add to Collection

Review Endocrinology & Metabolism

Crosstalk between Estrogen Signaling and Breast Cancer Metabolism

Eylem Kulkoyluoglu-Cotul et al.

TRENDS IN ENDOCRINOLOGY AND METABOLISM (2019)

Add to Collection

Article Oncology

Potential of osteopontin in the management of epithelial ovarian cancer

Katarina Cerne et al.

RADIOLOGY AND ONCOLOGY (2019)

Add to Collection

Review Oncology

Epigenetics in ovarian cancer

Yanina Natanzon et al.

SEMINARS IN CANCER BIOLOGY (2018)

Add to Collection

Article Biotechnology & Applied Microbiology

Slingshot: cell lineage and pseudotime inference for single-cell transcriptomics

Kelly Street et al.

BMC GENOMICS (2018)

Add to Collection

Article Oncology

Ovarian Cancer Statistics, 2018

Lindsey A. Torre et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2018)

Add to Collection

Review Cell Biology

The role of osteopontin in the progression of solid organ tumour

Hailin Zhao et al.

CELL DEATH & DISEASE (2018)

Add to Collection

Article Oncology

Breast cancer risk in premalignant lesions: osteopontin splice variants indicate prognosis

Kinga Walaszek et al.

BRITISH JOURNAL OF CANCER (2018)

Add to Collection

Article Multidisciplinary Sciences

Single-cell reconstruction of the early maternal-fetal interface in humans

Roser Vento-Tormo et al.

NATURE (2018)

Add to Collection

Article Biochemical Research Methods

Reversed graph embedding resolves complex single-cell trajectories

Xiaojie Qiu et al.

NATURE METHODS (2017)

Add to Collection

Article Oncology

MPO density in primary cancer biopsies of ovarian carcinoma enhances the indicative value of IL-17 for chemosensitivity

Raoul A. Droeser et al.

BMC CANCER (2016)

Add to Collection

Article Oncology

Reproductive and hormonal factors in relation to survival and platinum resistance among ovarian cancer cases

Amy L. Shafrir et al.

BRITISH JOURNAL OF CANCER (2016)

Add to Collection

Article Oncology

Ovarian Cancer Risk Factors by Histologic Subtype: An Analysis From the Ovarian Cancer Cohort Consortium

Nicolas Wentzensen et al.

JOURNAL OF CLINICAL ONCOLOGY (2016)

Add to Collection

Review Biochemistry & Molecular Biology

Effect of steroid hormones, estrogen and progesterone, on epithelial mesenchymal transition in ovarian cancer development

So-Ye Jeon et al.

JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2016)

Add to Collection

Review Oncology

The role of myeloid cells in cancer therapies

Camilla Engblom et al.

NATURE REVIEWS CANCER (2016)

Add to Collection

Article Biochemistry & Molecular Biology

Interleukin-17 produced by tumor microenvironment promotes self-renewal of CD133+ cancer stem-like cells in ovarian cancer

T. Xiang et al.

ONCOGENE (2015)

Add to Collection

Article Multidisciplinary Sciences

Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma

Anoop P. Patel et al.

SCIENCE (2014)

Add to Collection

Article Oncology

MUC16 (CA125) regulates epithelial ovarian cancer cell growth, tumorigenesis and metastasis

Catherine Theriault et al.

GYNECOLOGIC ONCOLOGY (2011)

Add to Collection

Article Public, Environmental & Occupational Health

Hormonal risk factors for ovarian cancer in premenopausal and postmenopausal women

Patricia G. Moorman et al.

AMERICAN JOURNAL OF EPIDEMIOLOGY (2008)

Add to Collection

Article Cell Biology

Osteopontin in metastatic lesions as a prognostic marker in ovarian cancers

Li Hong Bao et al.

JOURNAL OF BIOMEDICAL SCIENCE (2007)

Add to Collection

Review Medicine, Research & Experimental

The multifaceted roles of osteopontin in cell signaling, tumor progression and angiogenesis

Goutam Chakraborty et al.

CURRENT MOLECULAR MEDICINE (2006)

Add to Collection

Review Cell Biology

Incessant ovulation, inflammation and epithelial ovarian carcinogenesis:: Revisiting old hypotheses

JS Fleming et al.

MOLECULAR AND CELLULAR ENDOCRINOLOGY (2006)

Add to Collection

Article Public, Environmental & Occupational Health

Effect of anovulation factors on pre- and postmenopausal ovarian cancer risk: Revisiting the incessant ovulation hypothesis

KH Tung et al.

AMERICAN JOURNAL OF EPIDEMIOLOGY (2005)

Add to Collection

Article Oncology

Osteopontin as an adjunct to CA125 in detecting recurrent ovarian cancer

JO Schorge et al.

CLINICAL CANCER RESEARCH (2004)

Add to Collection

Article Oncology

Differential expression of osteopontin and bone sialoprotein in bone metastasis of breast and prostate carcinoma

G Carlinfante et al.

CLINICAL & EXPERIMENTAL METASTASIS (2003)

Add to Collection

Article Oncology

Hormonal carcinogenesis

BE Henderson et al.

CARCINOGENESIS (2000)

Add to Collection

© Peeref 2019-2024. All rights reserved.